Sonio has developed an AI-enabled SaaS guiding practitioners during prenatal ultrasound scans to optimize prenatal diagnosis. The company’s solutions include Sonio Diagnostics, Sonio Pro, and Sonio Share. Sonio Diagnostics combines the patient’s medical history, genetic and biological data, and ultrasound semiology to assist physicians on the path to the right diagnosis. Sonio Pro is made …

A spin-out of the Ophthalmology Department of the University Medical Center Groningen, Reyedar (previously known as Reperio Medtech) uses eye-tracking sensors coupled with deep learning to detect early symptoms of age-related degenerative diseases such as glaucoma, Parkinson’s, and multiple sclerosis. Early diagnosis is expected to improve the outcome of treatment and also healthcare costs. Reyedar …

Neko Health’s vision is to create a healthcare system that can help people stay healthy through preventive measures and early detection with the help of sensors and AI. To that end, the company has developed a new medical scanning technology concept to make it possible to do broad and non-invasive health data collection that is …

hema.to provides fully automated, AI-powered diagnosis recommendations for blood cancer from flow cytometry data. This, in turn, increases efficiency and quality for hemato-oncology labs using hema.to’s cloud-based platform. In order to use it, diagnosticians upload flow data files, and the solution provides them with clinical indications and diagnostic recommendations, which follow expert consensus.

The company has developed an AI tech called SEPSI-SCORE, which is capable of forecasting pathologies. Compatible with all major EHR systems using FHIR technology, it analyzes the data of thousands of patients in real time and accurately identifies the complication risks. Certified in 2021, SEPSI-SCORE can alert up to 48 hours before the first symptoms …

Founded as a spin-off of the University Hospital of Bern, Inselspital – machineMD is developing a novel diagnostic device that enables complete standardized and automated neuro-ophthalmic examinations. Uniquely combining virtual reality and artificial intelligence, the device will measure biomarkers such as eye and pupil movements that can be used in the early diagnosis of brain …

Riding the wave: Endodiag is part of the global femtech industry, which is expected to grow at a CAGR of 13% from 2021 to 2026.

Kheiron Medical is on a mission to help breast cancer patients live longer, better lives through earlier detection. Its solution, called Mia (Mammography Intelligent Assessment), combines new deep learning methods, data science, and radiology insights to help doctors find malignancies in mammograms. Whilst many AI technologies are not designed to be inclusive, Kheiron’s technology has …

MindPeak builds automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Its tools assist cancer experts in providing reliable and reproducible diagnoses. This frees specialists from tedious, repetitive tasks such as the quantification of cells or biomarkers and allows them to focus on tasks where their human expertise is indispensable. The company …

Elypta is a molecular diagnostics company focused on reducing cancer mortality through early detection. Elypta is pioneering a metabolism-based liquid biopsy and measures the GAGome, which are system biomarkers of tumor metabolism. Machine learning algorithms are then used to detect signatures of cancer non-invasively. Elypta is advancing a broad clinical program across different cancers, with …

Born at the University of Oxford, Ultromics provides autonomous echocardiography analysis through its AI solutions, empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease. EchoGo Heart Failure is a novel AI device built to indicate heart failure with preserved ejection fraction (HFpEF) by looking only at the apical four-chamber (A4C) echocardiography view. The …

Methinks has developed medical imaging software that detects cerebral artery occlusions and hemorrhages using artificial intelligence without the need for a CT scan with contrast. The company’s tech reduces time-to-treatment, enabling radiologists to communicate with hospitals, stroke units, and healthcare professionals. While Methinks is currently focusing on strokes, the second cause of death and a …

EarlySight aims to reduce vision loss by enabling efficient detection and better monitoring of eye diseases. The company develops a high-performance eye imaging instrument in the form of a unique ophthalmic camera, empowering doctors to see the first disease impacts. Its technology allows visualizing the morphology of many cells in the retina that are playing …